ATTR Amyloidosis Wild Type: Clinical Trials

1 trial for ATTR Amyloidosis Wild Type, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow ATTR Amyloidosis Wild Type: new trials by email Literature Review of ATTR Amyloidosis Wild Type trials Research Report on ATTR Amyloidosis Wild Type

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt)
Dobutrex - ATTR Amyloidosis Wild Type
Phase 1 / Phase 2RecruitingSteen Hvitfeldt Poulsen152024-04-082026-06-01

Narrower conditions

Amyloid Neuropathies, Familial (1)

Broader conditions

Amyloid Neuropathies (1)  ·  Amyloidosis (1)  ·  Amyloidosis, Familial (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Metabolic Diseases (1)  ·  Metabolism, Inborn Errors (1)  ·  Nervous System Diseases (1)  ·  Neurodegenerative Diseases (1)  ·  Neuromuscular Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Peripheral Nervous System Diseases (1)  ·  Proteostasis Deficiencies (1)

Interventions

Dobutamine (1)

Sponsors

Steen Hvitfeldt Poulsen (1)

Countries

Denmark (1)

NIH funding

2023 (1)